Dwi Oktari Erfanti Purwasasmita

Dr. Dwi Oktari Erfanti Purwasasmita

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
TYTetty Yuniati
Tetty Yuniati
FKFiva Aprilia Kadi
Fiva Aprilia Kadi
APAris Primadi
Aris Primadi
DPDwi Oktari Erfanti Purwasasmita
Dwi Oktari Erfanti Purwasasmita
JSJohanes Edy Siswanto
Johanes Edy Siswanto
AWAhmedz Widiasta
Ahmedz Widiasta
Background Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine has been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages. Unfortunately, serum creatinine levels have some limitations, such as the delayed increase among AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. The present study aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods A prospective-cohort study conducted at Hasan Sadikin General Hospital, Bandung, on preterm neonates with a gestational age of 28 – 34 weeks, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Results Serum NGAL measurement showed better positivity rate than creatinine (KDIGO and nRIFLE) in detecting early AKI in neonates, with values of 81.8, 24.7, and 10.4, respectively. Conclusion NGAL can be used as a modality in detecting AKI in neonates earlier.

25 February 2026 in Kidney and Dialysis
Verified
Journal Article
Open access
PDF file
TYTetty Yuniati
Tetty Yuniati
FKFiva Aprilia Kadi
Fiva Aprilia Kadi
APAris Primadi
Aris Primadi
DPDwi Oktari Erfanti Purwasasmita
Dwi Oktari Erfanti Purwasasmita
JSJohanes Edy Siswanto
Johanes Edy Siswanto
AWAhmedz Widiasta
Ahmedz Widiasta
Background: Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine levels have been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages, but unfortunately have some limitations, such as their delayed increase during AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. In the present study, we aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods: We conducted a prospective-cohort study on preterm neonates with a gestational age of 28–34 weeks at Hasan Sadikin General Hospital, Bandung, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Serum NGAL was measured using the Elabscience® Human NGAL ELISA kit; NGAL positivity was defined as serum NGAL > 150 ng/mL for exploratory classification. Results: Serum NGAL measurement showed a better positivity rate in detecting early AKI in neonates than creatinine (KDIGO and nRIFLE), with values of 81.8, 24.7, and 10.4, respectively. Conclusions: NGAL can be used as a modality for detecting AKI earlier in neonates.